. Like other herpesviruses, EBV and KSHV can establish latent, non-productive infections (that is, infections during which viral genomes exist in host cells without the production of infectious viral particles). In contrast to other herpesviruses, gammaherpesviruses are particularly adept at establishing stable latent infections in proliferating host cells. During gammaherpesvirus latency, the viral genomes are maintained in the host nuclear compartment as multicopy, non-integrated circular genomes that have chromatin structures similar to that of the host chromosome. These latent genomes, which are known as episomes or minichromosomes, have similar features to the host cell chromosome, which enable them to be transcribed and replicated by the host cell machinery. In addition, the viral genome is epigenetically modified, which allows the virus to fine-tune its gene expression patterns in response to changes in the host cell environment. Moreover, epigenetic features provide the heritable memory that is required to maintain a consistent gene expression pattern during multiple divisions of proliferating host cells 5, 6 . This Review focuses on recent work that highlights the importance of chromatin assembly, epigenetic modifications and chromatin-organizing factors in controlling the establishment of gammaherpesvirus latency. I discuss some of the key steps of primary viral infection and consider how each stage of infection may contribute to the generation of the latent viral episome. The major events include the assembly of viral chromatin, the patterning of histone post-translational modifications and DNA methylation, and the formation of higher-order chromosome conformations that coordinate gene expression programmes and maintain epigenetic memory during cell division.
Early epigenome establishment
Gammaherpesviruses enter the host cell nucleus as naked, linear DNA genomes and are protected by a virally encoded protein capsid that is delivered to the nuclear compartment (FIG. 1) . These early events, which include receptor engagement and capsid transport, are likely to set the stage for viral gene expression in the nucleus
. How the naked, unmodified viral DNA is assembled in the nucleus into a functional circular minichromosome that is competent for programmed gene expression and DNA replication remains poorly understood. The processes of genome circularization and chromatinization are thought to be key regulatory events that are crucial for the establishment of latent infection.
Viral genome circularization.
Genome circularization is likely to be important for protecting viral DNA ends and establishing a genome structure that is capable of completing the gammaherpesvirus life cycle the terminal repeat transcripts encoding latent membrane protein 2A (LMP2A) and LMP2B, which promote B cell proliferation and suppress the reactivation of the viral lytic cycle 8 . For KSHV, circularization is necessary to generate an intact episome maintenance element, which consists of multiple tandem copies of the viral terminal repeats 9 . Circularization is thought to be necessary for rolling-circle DNA replication, which seems to be the conserved mechanism of all herpesvirus lytic cycle DNA replication 10 . Lytic cycle DNA replication may also be required for the amplification of the viral genome before latency is established 11 . This is consistent with the observation that viral lytic gene products are produced transiently during the early stage of primary infection 11 . Circularization is an inefficient process and can be detected for only a subset of genomes at 24 hours post infection 12 . Circularization of gammaherpesvirus genomes is thought to involve DNA end processing and homologous recombination, followed by ligation. In support of a requirement for DNA end processing is the finding that linear EBV virion DNA has asymmetric end structures -one blunt end and one with a single base overhang 13 -which suggests that additional end processing is required for ligation. A role for homologous recombination is based on the finding that the terminal repeat copy number changes upon circularization during primary EBV infection 14 . Genomes that fail to circularize can integrate into the host chromosome, but these integrated genomes frequently lose essential genetic information and viral function 12, 15 . Genome circularization might also be necessary for proper chromatinization (see below). Linear genomes are known to activate the host DNA damage response (DDR), which can function as a potent antiviral defence 16 . The host DDR is tightly coordinated with chromatinization, as it is well established that double-strand breaks are subject to histone modifications, especially the phosphorylation of histone H2A.X mediated by ataxiatelengiectasia mutated (ATM) kinase 17 . The ATM pathway has been implicated as a control point for gammaherpesvirus primary infection 18 . Primary EBV infection activates ATM, and inhibitors of ATM increase the number of cells that become immortalized by EBV latent infection. Upon detection of damage, ATM phosphorylates histone H2A.X to generate γH2A.X and initiates the DDR 19 . For the mouse gammaherpesvirus MHV68 (mouse herpesvirus 68), ATM kinase activity and γH2A.X formation support chronic infection 20, 21 . For KSHV, γH2A.X is enriched at the terminal repeats and contributes to episome maintenance 20, 22, 23 . Together, these findings suggest that genome circularization is coordinated with host DDR-dependent histone modifications and chromatin assembly to promote the establishment of latency.
Viral genome chromatinization.
Cellular DNA is packaged with proteins known as histones to form chromatin. This condensed configuration, which is mediated by several host factors, ensures that the genome is protected from DNA damage and enables the tight regulation of gene expression 24 . Chromatin assembly after primary infection is likely to be a crucial determinant of gammaherpesvirus fate. Failure to establish the appropriate nucleosome positions and epigenetic modifications might account for variability in viral genome expression. Most infecting gammaherpesvirus linear genomes fail to establish stable episomal infections, and it is possible that improper circularization or chromatinization accounts for this high failure rate 25, 26 . For alphaherpesviruses, specific histone chaperones (for example, ASF1 (anti-silencing function 1)) and histone variants (for example, H3.3) have been suggested to Kaposi's sarcoma-associated herpesvirus (KSHV) to their receptors CD21 and ephrin A2, respectively, activates signalling pathways that can modify nuclear factors that are important for viral gene expression. Entry of the viral DNA into the nucleus activates IFNγ-inducible 16 (IFI16), leading to inflammasome activation (in the case of KSHV) and may trigger the DNA damage response (DDR) following recognition by ataxiatelengiectasia mutated (ATM) kinase. The linear genome then undergoes circularization and chromatinization, which results in the formation of a stable episome. The viral tegument proteins ORF75 (for KSHV) and major tegument protein BNRF1 (for EBV), have a key role in promoting chromatinization by disrupting proteins in promyelocytic leukemia nuclear bodies (PML NBs), for example death domain-associated protein (DAXX) and transcriptional regulator ATRX (not shown).
Histone deacetylases (HDACs) . A family of enzymes that remove an acetyl group from lysine residues on histone tails. HDACs typically promote 'closed' (repressive) chromatin, and reverse the action of histone acetylases that promote 'open' (active) chromatin.
be cofactors in lytic infection 8, 27, 28 . The role of histoneloading factors in gammaherpesvirus infection has not been addressed directly, but it can be inferred from their interactions with some viral tegument proteins. All gamma herpesviruses encode a class of tegument protein that target the cellular factors involved in chromatinization, including the EBV major tegument protein BNRF1, KSHV ORF75, MHV68 ORF75c and herpesvirus saimiri (HVS) ORF3. Each of these proteins target components of promyelocytic leukaemia nuclear bodies (PML NBs; also known as ND10), which consist of cellular proteins that regulate chromatin assembly (for example, PML, nuclear autoantigen SP100, death domain-associated protein (DAXX) and ATRX) and have a central role in the intrinsic resistance to viral nuclear infection [29] [30] [31] . For example, DAXX and ATRX form a protein complex that loads the histone variant H3.3, resulting in the suppression of transcription at repetitive DNA elements [32] [33] [34] . DAXX alone can mediate transcriptional repression through its interaction with histone deacetylases (HDACs) 35, 36 . Other components of PML NBs, including SP100, have also been implicated in the transcriptional regulation of viral genomes 37, 38 . Interestingly, the gammaherpesvirus tegument proteins target different components of the PML NBs using non-conserved regions, despite substantial evolutionary homology elsewhere in the proteins. EBV BNRF1 interacts with DAXX and prevents ATRX localization to PML NBs 39 . MHV68 ORF75c and HVS ORF3 interact with and degrade PML and SP100, respectively 40 . Destruction of PML NBs is thought to be necessary for the completion of herpesvirus lytic cycle gene expression and DNA replication 41 . However, BNRF1 does not degrade any component of the PML NBs, but merely prevents ATRX localization and binding. It is therefore tempting to speculate that BNRF1 remodels but does not destroy PML NBs to permit latent cycle viral gene expression but still restrict lytic gene expression.
Control of latent cycle transcription
Human gammaherpesvirus primary infection typically results in a slow, abortive lytic cycle that competes with a more robust latent cycle gene expression programme. Chromatin and other epigenetic features have important roles in regulating the balance between different gene expression programmes. Here, I discuss the gene expression programmes of EBV and KSHV and consider how chromatin organization is a common regulatory mechanism for each virus.
EBV transcriptional regulation. EBV can establish at least four distinct latency-associated transcription patterns, which are known as latency types 42, 43 . The most restrictive transcriptional programme is latency type 0 (which is observed in non-cycling, resting memory B cells), during which no viral gene products are synthesized. Type I latency (which is observed in proliferating memory B cells and Burkitt's lymphoma cells) involves the expression of Epstein-Barr nuclear antigen 1 (EBNA1; also known as BKRF1) and several non-coding RNAs. Type II latency is defined by the expression of one or several latency membrane proteins (LMP1, LMP2A or LMP2B) in addition to the type I gene products, and this type of latency is observed in Hodgkin's lymphomas and epithelial cell carcinomas. Type III latency (which is observed in highly proliferating B cells and immortalized cell lines) is the most permissive for transcription, during which all of the viral genes associated with latency are detected, including EBNA1, EBNA leader protein (EBNA-LP), EBNA2, EBNA3A, EBNA3B, EBNA3C, LMP1, LMP2A and LMP2B.
During the early phase of EBV infection of naive B cells, the first latent viral gene product detected is EBNA2 mRNA, the transcription of which initiates at the W repeat promoter (Wp) (FIG. 2) . EBNA2 is essential for the transcriptional activation of host and viral genes that are required for B cell proliferation. This is achieved through interactions with the host transcription factors RBP-Jκ (recombination signal binding protein for immunoglobulin κJ region; also known as CBF1 and CSL) and PU.1 (REF. 44 ). As EBNA2 accumulates, it associates with RBP-Jκ-binding and PU.1-binding sites on viral promoters. This causes transcription to shift from Wp to an upstream promoter known as the C promoter (Cp). Transcription that initiates from Cp gives rise to a much larger (~100 kb) polycistronic and alternatively spliced transcript that generates EBNA1, EBNA-LP, EBNA2, EBNA3A, EBNA3B and EBNA3C. EBNA2 is also required for the transcriptional activation of the LMP1 and the LMP2 promoters, through interactions with RBP-Jκ or PU.1 (REFS 45, 46) . Additional host factors involved in this process include paired box protein PAX5 (also known as BSAP), which is required for early
Box 1 | Viral entry and recognition
The earliest event that influences the outcome of gammaherpesvirus infection is the interaction of the viral particle with host cell surface receptors (FIG. 1) . The binding of Epstein-Barr virus (EBV) to CD21 (REF. 181 ) and of Kaposi's sarcoma-associated herpesvirus (KSHV) to ephrin A2 (REFS 182, 183) initiates cell signals, such as phosphoinositide 3-kinase (PI3K) and AKT (also known as PKB) activation, that can modify nuclear factors important for viral gene expression. The viral genomes are then transported to the nuclear pore through a protective viral capsid such that the viral DNA is never exposed to cytoplasmic DNA sensors 184 . The interaction of the viral capsid with the nuclear pore results in the injection of the single naked viral genome into the nucleus 185 . How these cytoplasmic events influence the outcome of viral DNA in the nucleus is not yet known, but they are likely to be important for the establishment of successful latent infection
In the case of KSHV, one of the earliest nuclear events is the interaction of viral DNA with IFN γ-inducible protein 16 (IFI16) 186, 187 , an AIM2-like receptor (ALR) that recognizes double-stranded DNA through its HIN200 domain 188 . Binding to viral DNA activates the inflammasome through a mechanism that involves the release of nuclear apoptosis-associated speck-like protein containing a CARD (ASC) and procaspase 1 into the cytoplasm 186 . Similar IFI16 recognition mechanisms have been described during the early stages of herpes simplex virus (HSV) infection 189, 190 . IFI16 has also been shown to associate with the EBV genome at all stages of latent infection, resulting in constitutive induction of the inflammasome 191 . It is not known how nuclear IFI16 interacts with the viral DNA nor how IFI16 activation of the inflammatory response alters the fate of viral infection. During early HSV infection, IFI16 is degraded by the viral tegument protein ICP0, which results in a block to this innate immune pathway 192 . The failure to inactivate IFI16 during KSHV and EBV infection may suggest that IFI16 is important for directing gammaherpesvirus to latency rather than lytic cycle gene expression. activation of Wp 47, 48 , and octamer-binding protein 2 (OCT2), which has been implicated in the activation of Cp 49 . EBV early gene expression is even more complicated, as genetic studies indicate that EBNA1 is also required for the transcriptional activation of Cp during primary infection of B cells 50 . This suggests that EBNA1 must be expressed before the switch to Cp-initiated transcription occurs 50 . EBNA1 mRNA is generated from Cp at later times in type III latency, but it is not clear how EBNA1 is produced during the earliest stages of B cell infection. In type I latency, EBNA1 is expressed from a constitutive promoter, termed the Q promoter (Qp), so it is tempting to speculate that EBNA1 transcripts during early phase infection originate from Qp, rather than Wp [51] [52] [53] . Qp has two high-affinity EBNA1-binding sites that result in autoinhibition by EBNA1; thus, it is possible that this inhibition of EBNA1 expression correlates with and may facilitate the switch to Cp-initiated transcription.
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The temporal order of transcription during primary viral infection is not completely clear, and it is possible that Qp-driven EBNA1 and Wp-driven EBNA2 are generated simultaneously and cooperate to reinforce the type III latency programme 52 . How type III latency evolves into the more restrictive type I or type II latency is also not entirely clear. It is known that in type I latency, Cp-driven transcription is repressed and only EBNA1 is transcribed by Qp. This promoter switch correlates with epigenetic changes at Cp and the LMP1 promoter, including DNA methylation of crucial transcription factorbinding sites 54, 55 . Factors that inhibit EBNA2-mediated transcriptional activation might also have a role in the switch from type III to type I latency.
EBV can also show partial lytic cycle gene activation during de novo infection of primary B cells; this has been referred to as the pre-latency phase 56 . During the process of establishing a latent infection, EBV transiently expresses some early-phase lytic cycle gene products, including the immediate-early protein Zta (also known as BZLF1; a DNA-binding protein that activates the transcription of most lytic cycle genes), but virion production is minimal 11 . Similarly, early but not late lytic cycle gene transcripts are detected in transcriptome analyses of latently infected lymphoblastoid cell lines (LCLs), which suggests that partial lytic cycle gene activity occurs in these cell populations 57 . These findings imply that partial lytic cycle gene expression is permitted during the establishment phase of latency and in some latently infected cells. Importantly, completion of the lytic cycle can be restricted at multiple levels, including the inhibition of viral gene expression 58 and protein function [59] [60] [61] .
KSHV transcriptional regulation. KSHV seems to show less variation in latency transcription than EBV, although heterogeneous gene expression has been reported in some latency models and tumour-derived cells 62 . Like EBV, KSHV primary infection typically leads to an abortive lytic infection, in which infected cells produce low levels of viral particles and primarily express genes of the latent transcriptional programme. The major latencyassociated transcript consists of a multicistronic message that encodes latency-associated nuclear antigen (LANA), viral cyclin and viral FLICE inhibitory protein (vFLIP; also known as ORF71). LANA is the KSHV orthologue of EBNA1 and can bind directly to the terminal repeat DNA to promote DNA replication and episome maintenance during latency 63, 64 ; viral cyclin and vFLIP are required for host cell cycle proliferation and survival 65 .
A strong initiator element has been identified at the core promoter for these latency transcripts 66, 67 . Alternative downstream promoters can initiate a transcript for vFLIP, kaposin (K12) and a cluster of viral micro RNAs (miRNAs) 68, 69 . In addition, the latency proteins, viral interleukin-6 homologue and viral interferon regulatory factor 3, are also detected in most models of KSHV latency and in KSHV-infected tumour cells 70, 71 . Some viral genes associated with the lytic cycle can be detected in the context of tumours; for example, in tumour isolates from primary effusion lymphoma, the lytic cycle gene viral G protein-coupled receptor (vGPCR; also known as ORF74) can be detected along with latency transcripts 72 , and sustained vGPCR expression is thought to be crucial for B cell tumorigenesis [73] [74] [75] [76] . As vGPCR is typically considered a lytic viral gene product, its expression in tumour cells may reflect the aberrant control of latent infection 75 . More recent studies suggest that KSHV can adopt different transcription patterns depending on the host cell type 62 . In human lymphatic endothelial cells (LECs), the KSHV lytic cycle immediate-early genes ORF45 and ORF50 are transcribed along with canonical latency genes (LANA, viral cyclin and vFLIP), but other lytic genes are not detected. One phenotypic consequence of this different gene expression programme is that LECs are more sensitive to treatment with rapamycin (which is an immunosuppressant that activates the growth control protein mammalian target of rapamycin (mTOR)), as the KSHV ORF45 protein induces chronic activation of mTOR 62 . These findings suggest that, similarly to EBV, KSHV might have different latency types and that both viruses might express some lytic genes without full commitment to lytic cycle DNA replication and viral production.
Ensuring expression of the viral epigenome As mentioned above, EBV and KSHV can establish stable and distinct transcriptional programmes during latent infection, which in the case of EBV reflect the different latency types [77] [78] [79] [80] . In many cases, these different latency types have been shown to have correspondingly different epigenetic modification patterns, which are known as 'epigenotypes' (REFS 55, 80) .
Epigenetic stabilization of latency programmes. DNA methylation patterns have been shown to have a key role in regulating both KSHV 81 and EBV latency types 54, 56, 78 . DNA methylation, which typically represses gene expression, occurs gradually after primary infection. For EBV, the slow rate of DNA methylation restricts lytic cycle gene activation, as DNA methylation is required for transcriptional activation of some viral genes by Zta 56, [82] [83] [84] [85] [86] [87] [88] [89] . Zta is unusual in that it can bind selectively to DNA with methylated cytosine 86 ; in fact, the methylation of some viral promoters is necessary for Zta-dependent binding, transcriptional activation and lytic gene expression 89 . Thus, the lack of DNA methylation provides a paradoxical restriction to EBV lytic cycle gene expression 56, 82 . In the case of KSHV, DNA methylation does not occur at constitutively active latency promoters, such as the LANA promoter, but instead occurs at several transcriptionally inactive regions. Similarly, in EBV, DNA methylation is absent at transcriptionally active latency promoters, as well as at other protected sites such as the latency-associated origin of replication (OriP) and Qp, which constitutively bind the episome maintenance protein EBNA1 (REF. 90 ). However, DNA methylation has been shown to repress Cp in type I latency, which results in EBNA2 and EBNA3 silencing 54 . The mechanisms that determine DNA methylation patterns are not yet understood, although it is possible that some sites are methylated owing to a lack of transcriptional activity ('methylation by neglect'), whereas others are spared DNA methylation owing to the protective effects of some DNA-binding proteins, such as EBNA1.
Histone modifications also have a central role in regulating EBV and KSHV latency. Many studies have shown that gammaherpesvirus latency could be disrupted using HDAC inhibitors 91 . Transcriptional activation of both latent and lytic genes correlates with changes in histone tail modifications at active promoter regions 92, 93 . These modifications include the well-established histone marks that are associated with eukaryotic gene activation, namely hyperacetylation of histone H3 and H4 amino-terminal tails, and trimethyl ation of H3 at lysine 4 (H3K4me3) 92, 93 . More recent genome-wide studies have indicated that EBV and KSHV have complex histone modification patterns during latent infection 57, 77, 81, [94] [95] [96] [97] . The epigenetic landscape of KSHV latent genomes has been examined in several cell types 81 and compared with reactivating genomes 96 . These studies revealed that the promoter region upstream of the lytic immediateearly gene ORF50, which encodes the lytic replication and transcription activator (Rta), is enriched with both activating (H3K4me3) and repressing (H3K27me3) histone modifications 81, 96 . This 'bivalent' control of gene expression is also found at the promoters of cellular genes that remain poised for activation during developmental switches 98 . The small molecule inhibitor of the H3K27me3 methylase EZH2, DZNep, was shown to stimulate KSHV lytic cycle gene activation 96 , which implies a role for H3K27me3 in promoting latency. The transcriptionally repressive effects of H3K27me3 are known to be mediated by the chromatin modulator Polycomb 99 , which suggests that these proteins have a central role in restricting the lytic cycle gene programme and chromatin structure of KSHV during latency.
Much of the data collected for the EBV epigenome has been derived from metadata analyses of the ENCODE ChIP-Seq (Encyclopedia of DNA Elements chromatin immunoprecipitation sequencing data collection) on LCLs that contain the EBV B95-8 genome 57 . The study indicated that type III latency EBV in LCLs has a complex organization of histone modifications, with high enrichment of H3K4me3 at the active Cp, LMP2A and LMP2 promoters and at the promoter region for RPMS1 and BART. In contrast to KSHV, these studies did not show a high level of repressive histone marks at the lytic promoters, which suggests that EBV latency is regulated by other mechanisms 96 .
Chromatin-organizing factors: CTCF and cohesins. The organization of histone modifications and nucleosome positioning is a key regulatory feature of eukaryotic chromosomes 100, 101 . How this process occurs de novo on newly infecting viral genomes and how these patterns are maintained during multiple cell divisions is crucial to our understanding of the epigenetic control of gammaherpesvirus latency. At least some of the nucleosome positions and histone tail modifications are directed by sequence-specific transcription factors and their cofactors. In addition, specialized factors such as the CCCTC-binding factor (CTCF) are known to function as chromatin-organizing factors [102] [103] [104] . CTCF can prevent the spread of repressive or active chromatin from one regulatory domain into another, and can prevent enhancer communication with a specific promoter (thus acting as an insulator). CTCF can also function in DNA loop formation, and it is possible that these structural loops serve as the molecular basis for other roles in chromatin boundary and enhancer insulator function [105] [106] [107] . DNA loop formation by CTCF commonly involves another cellular protein complex, known as cohesin. Cohesin, originally characterized for its role in sister chromatid cohesion, is a multiprotein complex that keeps newly synthesized chromosomes in close contact during early mitosis and is necessary for faithful chromosome segregation during cell division 102, 108, 109 . Cohesin has been found to colocalize with CTCF at many cellular chromosomal positions and supports DNA loop structures, which are important for gene regulation 102, 108 . Co-occupancy of CTCF and cohesin has also been observed on gammaherpesvirus episomes during latent infections 57, 97, 110 . In the KSHV episome, a cluster of three CTCFbinding sites within the first intron of the major latency transcript strongly colocalizes with cohesin 110 . The function of CTCF and cohesin binding within this cluster seems to be multifactorial. Genetic disruption of the CTCF-binding sites in KSHV bacmids destabilizes episomal maintenance in some cell lines and reduces the efficiency of de novo infection 110 . Genomes containing mutated CTCF-binding sites show defects in latency transcript regulation, with a shift towards the unspliced form of the multicistronic transcript 111 . Mutation of CTCF-binding sites also disrupts cohesin and RNA polymerase II (Pol II) binding 111 . The complexity of regulatory events surrounding CTCF-binding sites suggests that they have a fundamental structural and organizational role in the viral chromosome (FIG. 3) .
One potential mechanism by which CTCF organizes chromatin might involve the disruption of the normal positioning of nucleosomes. At the KSHV latency promoter, the cluster of three CTCF-binding sites prevents the positioning of a second nucleosome downstream of the latency transcript initiation site 111 . As the first nucleosome downstream of the transcription start site is commonly enriched in modifications that are associated with Pol II function (for example, H3K4me3 and acetylation of H3 at lysine 9 (H3K9ac)) 112 , it is possible that CTCF-binding sites prevent the processive spreading of these modifications and thereby modulate transcription elongation and mRNA splicing of the complex latency transcripts.
A chromatin boundary function for CTCF has been observed at two regulatory regions in the EBV episome. The CTCF-binding site upstream of Qp protects this core promoter from DNA methylation and consequent transcriptional silencing. This site also blocks the spread of the repressive histone modification H3K9me3 that is just upstream of Qp 90, 113 . A CTCF-binding site located between the Cp and the EBNA1-binding sites at OriP Figure 3 | Establishment of the KSHV epigenome. a | The major latencyassociated transcripts of Kaposi's sarcoma-associated herpesvirus (KSHV) comprise latency-associated nuclear antigen (LANA), viral cyclin (vCyc) and viral FLICE inhibitory protein (vFLIP). During transcription of these viral genes, transcription of the lytic transcripts ORF50 and ORF45, ORF46 and ORF47 is inhibited. However, the lytic transcript viral G protein-coupled receptor (GPCR) can be detected. Latency is stabilized by a CCCTC-binding factor (CTCF) -cohesin loop between the immediate-early promoter region (ORF50 and ORF45, ORF46 and ORF47) and the latency control region (LANA-vCyc-vFLIP). b | RBP-Jκ (recombination signal binding protein for immunoglobulin κJ region) functions as a scaffold for the transcriptional activation of KSHV immediate-early lytic cycle genes by replication and transcription activator (Rta; encoded by ORF50) during the lytic cycle and for the repression of this transcription by LANA during latency.
Euchromatic
Regions of open chromatin that are more accessible to DNA-binding proteins and transcription initiation. By contrast, heterochromatic refers to 'closed' chromatin that is less accessible to transcription factors.
Zn hook
A structure that occurs when Zn mediates the interaction between two different molecules of the same protein through homotypic interactions, such that four amino acids (two from each protein monomer) form a cage to coordinate with a Zn atom at its centre.
Chromatin conformation capture
(3C). A method that can be used to measure the interaction between different DNA sites on the same or different chromosomes in vivo. It determines whether two different DNA regions are in close proximity to each other in vivo and is used to show that promoters and enhancers form interactions through DNA looping.
G-quadruplex
(also known as G-quartets or G4-DNA). DNA or RNA structures that can arise in G-rich stretches where four G bases form a planar structure that can be stacked to yield higher-order stable structures. G-quadruplexes can form between one (intramolecular) or more (intermolecular) DNA or RNA molecules.
can regulate EBNA1-mediated transcriptional activation of Cp 114, 115 . Specifically, CTCF binding between OriP and Cp might prevent the unwarranted spread of euchromatic H3K4me3 (which is enriched around OriP in most latency types) into Cp, especially in the more restrictive latency types I and II when Cp is repressed.
CTCF-binding sites might also provide chromatin boundary functions at the lytic control region of the KSHV episome, which, as mentioned above, has bivalent histone modifications 77, 81 . As CTCF-binding sites have been identified at the boundaries of lytic promoter regions, it is possible that CTCF, together with cohesin, protects this bivalent chromatin organization 116 . ChiP assays suggest that CTCF also functions to retain Pol II at the lytic promoter in a conformation poised for rapid response to reactivation signals 116 . Phosphorylated Pol II (which is associated with transcription initiation but not yet competent for elongation) is enriched at the KSHV lytic control region 116 , so the presence of CTCF might provide a boundary for trapping poised, but not elongating, Pol II at this location.
Chromatin conformations that regulate viral gene expression. Higher-order chromosome structures, such as promoter-enhancer DNA loop interactions, contribute to the coordinated control of eukaryotic gene expression 100 . For gammaherpesviruses, it is not known how latent and lytic promoters that are located tens of kilobases away from each other can coordinate the regulation of their transcriptional programmes. DNA loops between transcriptional regulatory elements have been identified in both EBV and KSHV latent genomes. In EBV type III latency, OriP functions as a transcriptional enhancer for both Cp and the LMP1 promoter 57, 117 . In both cases, the physical interaction involves the formation of DNA loops, which are dependent on CTCFbinding sites and cohesin 57 . Cohesin colocalizes with the CTCF sites at both promoters, and depletion of cohesin subunits using short hairpin RNA (shRNA) disrupts loop formation and dysregulates transcription from both promoters. Interestingly, in type I latency, when Cp and LMP1 and LMP2 promoters are repressed, OriP forms a DNA loop with the active Qp 117 . This suggests that OriP functions as a transcriptional enhancer that selectively loops with the active promoters for each latency type (FIG. 2) .
DNA loops that involve OriP may be mediated, in part, by EBNA1, which is known to bind multiple sites within OriP and can form a short DNA loop between these sites 118, 119 . The EBNA1 N-terminal domain is known to have transcriptional enhancer function, as point mutations in the EBNA1 N-terminal unique region 1 (UR1) disrupt the transcriptional activation of Cp 50 . UR1 was shown to coordinate a Zn atom through a pair of cysteine residues that are essential for EBNA1 homotypic interactions and transcriptional enhancer function 120 . Furthermore, Zn binding and homotypic interactions were shown to be redox-sensitive, which suggests that EBNA1-mediated loop formations are regulated by oxidative stress 120 . These findings support a model whereby EBNA1 forms a Zn hook-like structure 121 that could regulate the long-distance interactions required for OriP loop formation and transcriptional enhancer function.
DNA regulatory loops have also been described for the KSHV episome 122 . Chromatin conformation capture (3C) studies revealed that the CTCF-cohesin site in the latency control region forms two loops: a short ~10 kb loop between the CTCF cluster in the first intron of LANA and the region at the 3′ end of K12, encompassing the major latency transcripts; and a larger loop between the CTCF-cohesin sites and the control region for lytic transcripts of ORF50 and ORF45, ORF46 and ORF47 (REF. 122 ). As noted above, the lytic control region is bracketed by CTCF-binding sites with a poised Pol II. The shRNA-mediated depletion of cohesin subunits leads to a loss of DNA loop structures (as measured by 3C analysis) and a robust stimulation of lytic transcription 122 , which suggests that the CTCF-cohesin complex at the latency control region functions as a repressor of lytic transcription. Thus, CTCF-cohesin-mediated loops can function in both activation and repression of viral transcription.
DNA replication and episome maintenance
Gammaherpesviruses are unique in their ability to maintain a stable copy number of viral episomes in proliferating host cells. This is accomplished by the coordination of viral gene expression, DNA replication and genome segregation. Episome maintenance requires binding of the virus proteins EBNA1 (for EBV) or LANA (for KSHV) to repetitive sequences in either OriP (for EBV) or the terminal repeats (for KSHV) 123 ; thus, these proteins and DNA regions are known as episome maintenance elements.
Tethering to host chromosomes. A key feature of episome maintenance is the ability to tether the viral genome to the host metaphase chromosome (FIG. 4a) to retain viral genomes in the nuclear and chromosomal domains during host cell division. Thus, tethering enables gamma herpesviruses to 'hitch a ride' on the host chromosome and maintain a stable copy number after host cell division. Both EBNA1 and LANA contain peptide motifs that mediate metaphase chromosome tethering. EBNA1 tethering is mediated by RGG-like motifs in the EBNA1 N-terminal domain, which interact with the host cell protein EBNA 1-binding protein (EBP2; also known as EBNA1BP2) [124] [125] [126] , with AT-rich DNA 127 and with G-quadruplex RNA 128 . For KSHV, attachment to the metaphase chromosome is mediated by binding of the LANA N-terminal domain to the core histones H2A and H2B 129 and of its carboxy-terminal domain to host cell chromatin proteins, including the bromodomain proteins BRD2 and BRD4 (REFS 130, 131) , which recognize acetylated histones. Together, these observations suggest that tethering of EBV and KSHV epigenomes is mediated by multiple interactions with host chromatin.
Promoting DNA replication. The gammaherpesvirus episome maintenance elements can also function as origins of DNA replication. Both EBNA1 and LANA can interact with the host replication factors, including Nature Reviews | Microbiology 
DNA catenations
Structures that form when DNA strands are entangled, for example when two replication forks collide to terminate DNA replication. Some catenations, including hemicatenanes, form when the newly replicated DNA strands are entangled. Most DNA catenations can be decatenated by topoisomerases.
the origin recognition complex (ORC) and replication protein A (RPA), to facilitate efficient replication origin formation. The precise mechanism by which EBNA1 and LANA stimulate origin formation remains poorly understood. EBNA1 and LANA can interact with ORC subunits, and the bromo-adjacent homology (BAH) domain of ORC1 has been implicated in EBNA1 binding 132 . The EBNA1 RGG-like motifs are required for replication function, and this correlates with the recruitment of ORC. In addition, G-quadruplex RNA has been shown to stimulate the interaction between EBNA1 RGG-like motifs and the ORC 133 . Although viral episome maintenance elements such as EBV OriP and KSHV terminal repeats can act as efficient replication origins, their function depends on poorly understood epigenetic features 134 . Histone acetylation and the enrichment of H3K4 trimethylation are known to influence origin selection on host chromosomes 135, 136 . Similar modifications are observed at gammaherpesvirus episome maintenance elements in cells with established latent infections 137, 138 . This may not be sufficient for the initiation of replication, as single-molecule studies indicate that DNA replication can initiate at sites outside of these episome maintenance elements [139] [140] [141] [142] [143] . Thus, replication initiation may not be a primary essential function of episome maintenance elements.
Partitioning the viral genome during cell division. The precise mechanism by which gammaherpesviruses partition their genomes to maintain a stable copy number is not yet known. Studies have shown that partitioning is non-random and is coupled to DNA replication 144 . One potential mechanism for active partitioning may involve the formation of DNA catenations between newly replicated DNA molecules [145] [146] [147] [148] . Two-dimensional agarose gel analyses reveal that DNA catenation-like structures form specifically at OriP (in EBV) and terminal repeats (in KSHV) 145, 146, 149 . DNA catenations are thought to provide a mechanism to attach newly replicated sister chromosomes to each other, in a similar way to sister chromatid cohesion for cellular chromosomes. This mechanism has been shown to be important for plasmid partitioning in yeast and bacteria, and has been referred to as 'chromosome kissing' (REF. 150 ). Both EBNA1 and LANA might induce DNA catenation formation at OriP and terminal repeats, respectively, by perturbing DNA polymerase and replication fork structure [145] [146] [147] [148] . Evidence to support this model is provided by studies showing that the host replication fork protection proteins, Timeless and Tipin, colocalize with OriP and have essential functions in EBV and KSHV episome maintenance 145, 146 . These studies suggest that gammaherpesvirus episome maintenance elements can form replication-dependent 
Reactivation and virus production
Reactivation from latency is required for the completion of the gammaherpesvirus life cycle and for the production of new infectious viral particles. Reactivation can be stimulated by various stress responses, which range from the unfolded protein response to hypoxia, as well as by cell differentiation signals. These pathways typically converge by activating transcription of the immediate-early genes, which can recruit numerous host cell regulators that modulate viral chromatin structure and function (for reviews, see .
The disruption of repressive chromatin may be an essential pathway for gammaherpesvirus reactivation. The viral immediate-early proteins, Zta for EBV and Rta for both EBV and KSHV, are required for transcriptional activation of lytic cycle genes 157 . Zta and Rta associate with histone acetyltransferases and chromatin remodelling proteins to stimulate the transcription of chromatinized viral episomes 158, 159 . KSHV Rta functions as an E3 ubiquitin ligase to degrade transcriptional repressor complexes, such as KSHV Rta-binding protein (K-RBP) and Hey1, which block KSHV lytic cycle transcription 160, 161 . In addition to these viral immediate-early proteins, recent studies have revealed that viral noncoding RNAs also regulate the lytic switch. The KSHV polyadenylated nuclear non-coding (PAN) RNA facilitates lytic cycle gene expression by disrupting Polycombmediated chromatin repression. PAN RNA was found to bind and recruit the histone H3K27 demethylases UTX and JMJD3 (also known as KDM6B) to reverse the Polycomb-mediated repression of KSHV immediateearly transcripts 162 . Interestingly, Polycomb-mediated repression is also the target of the EBV-encoded EBNA3C, but in this case, EBNA3C promotes Polycomb repression on host tumour suppressor genes 163, 164 . It is not yet known whether or not EBNA3C recruits H3K27 methylases and Polycomb to repress viral lytic genes and thus stabilize latency.
One of the emerging themes in the regulation of gamma herpesvirus reactivation is that factors that promote latency can also repress lytic reactivation; for example, the loss of EBNA1 or LANA increases viral lytic cycle gene expression, which suggests that these latency maintenance proteins also repress lytic gene expression [165] [166] [167] . LANA functions as a transcriptional repressor that can interact with RBP-Jκ-binding sites at lytic promoters, including the promoters for immediateearly gene transcripts 168, 169 . EBNA1 can also repress lytic gene transcription during latency, as its depletion leads to lytic cycle activation 170 ; however, the mechanism for EBNA1-mediated transcriptional repression of EBV lytic gene transcription is not yet understood (FIG. 5) .
Many other factors contribute to the balance between latent and lytic gene expression. As gammaherpesviruses encode numerous miRNAs, it is not surprising that one of the functions of these non-coding RNAs is to stabilize latency by maintaining repressive epigenetic marks. For example, the KSHV miRNA K12-5 was shown to prevent lytic cycle gene expression by increasing global viral and cellular DNA methylation levels 171 . This was achieved through the downregulation of the host protein retinoblastoma-like 2 (RBL2), which represses the DNA methyltransferase DNMT3B 171 . The heterogeneity of viral genomes and host cells is also an important consideration in gammaherpes virus gene regulation. It is well known that gammaherpesvirus reactivation from latency is stochastic and multifactorial 172 , as only a subset of cells and genomes respond to an activation signal. Global epigenetic regulators such as HDAC inhibitors, demethylating agents and histone methylase inhibitors can stimulate partial lytic reactivation, and the extent of reactivation varies among cell and latency types. The refractory nature of viral latency in some cell types has been difficult to explain and remains a challenge in the treatment of lytic infections, during which some cells fail to respond to a reactivation signal. In one study, the refractory cells showed high levels of signal transducer and activator of transcription 3 (STAT3) expression 173, 174 , whereas in another study the block to reactivation correlated with increased levels of early B cell factor 1 (EBF1) 175 . Several additional host proteins, including the repressor zinc-finger E-boxbinding homeobox (ZEB) 58, 176, 177 , Jun dimerization protein 178 and OCT2 (REF. 60 ), have been shown to block lytic reactivation. In addition, viral immediate-early proteins can be inhibited by post-translational modifications 59 and by epigenetic modifications of the viral genome 179 . Taken together, these studies suggest that combinatorial control and epigenetic variations of the viral genome may explain the sporadic and stochastic process of reactivation from latency.
Conclusions
Gammaherpesvirus latency is a complex and sophisticated form of genetic parasitism that involves the formation of a stable minichromosome that is highly responsive to the host cell environment and developmental status.
The establishment of latency involves a competition between lytic gene expression and the expression of a more dominating class of latency genes. Stable latent infection depends on the acquisition of several epigenetic features, including circularization, chromatinization and the post-translational modifications of histones and DNA. In addition, higher-order chromatin structures, such as DNA loops and catenations, might have a role in gene regulation and episome maintenance. These epigenetic features are necessary for stable gene expression programmes and the faithful transmission of viral genomes to daughter host cells.
Despite the enormous wealth of information available about gammaherpesvirus latency, there are considerable gaps in our knowledge of how latency is established and maintained. For instance, it is not yet known what host cell factors are primarily responsible for the restriction of gammaherpesvirus lytic gene expression during primary infection. We also do not know what epigenetic events are the principle drivers of viral latency. Although we know that the formation of a stable viral episome involves nucleosome assembly and histone modifications, it remains unclear how nucleosome position and histone modification patterns are established on the newly infecting viral genomes or how these patterns of chromatin organization are maintained over cell division cycles.
It will also be important to determine how higherorder chromosome conformations are established and how these structures facilitate interactions between enhancers, such as OriP, and the appropriate promoter elements selected for transcriptional activation, such as Cp and Qp.
How the viral episomes are replicated and segregated during each cell cycle might also be subject to important epigenetic control, including the formation of DNA catenations that promote sister chromatid cohesion after DNA replication. Whether these epigenetic factors allow the gammaherpesvirus genomes to survive as stable episomes and maintain a stable copy number in proliferating cells is an important unanswered question.
Finally, the mechanism of gammaherpesvirus persistence in cancer cells may be different from that in normal cells 180 . Abberations in the prototypical epigenetic programmes may account for the rare incidence of virus-associated tumour formation. At present, we do not know whether specific epigenetic modifications correlate with cancer cells and whether these are inherently different to the latency associated with normal nonmalignant cells. Understanding the detailed mechanisms of each of the processes discussed in this Review and their potential aberrations in virus-associated cancers should provide insights into the oncogenic potential of gammaherpesvirus latency and may lead to novel strategies for therapeutic interventions that target latent infection and viral carcinogenesis.
Note added in proof
The recently solved X-ray crystal structures of KHSV and MHV68 LANA proteins 193, 194, 195 confirm that these proteins share a common structural fold with EBV EBNA1, and provide new insight into how DNA binding and oligomerization regulate viral DNA replication and episome maintenance during gammaherpesvirus latency. In addition, these studies reveal important new interaction modes between LANA and BRD4, suggesting that viral interactions with chromatin regulatory factors have many more surprises in store.
